Ryan Sullivan

85PUBLICATIONS

577CO-AUTHORS

Molecular targetsTumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (85)

Sort by Publication Date:

|Jun 26, 2026

Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma.

|Jun 25, 2026

Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|Jun 24, 2026

Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

|Jun 01, 2026

Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase 2b KEYNOTE-942 Study.

|May 18, 2026

Lipid Nanoparticle-encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ Plus Durvalumab Induces an Immunostimulatory Effect Within the Tumor Microenvironment in Patients with Advanced Solid Tumors.

|May 04, 2026

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

Pageof 15

Frequent Collaborators

13 joint publications

Genevieve Marie Boland

11 joint publications

Meghan J Mooradian

10 joint publications

Keith T Flaherty

9 joint publications

Priscilla K Brastianos

Harriet M Kluger

Paolo A Ascierto

Michael Postow

Hussein Tawbi

Michael White

Scott L Carter

Frequent Collaborators

13 joint publications

Genevieve Marie Boland

11 joint publications

Meghan J Mooradian

10 joint publications

Keith T Flaherty

9 joint publications

Priscilla K Brastianos